News
Cow comfort, especially in the dry period, is the most important part of mastitis management, said Ben Smith, owner of Cool ...
BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...
16h
Pharmaceutical Technology on MSNLEO Pharma secures rights to Boehringer’s Spevigo for $105mLEO has plans for Spevigo beyond generalised pustular psoriasis as it looks to boost its dermatological pipeline.
Both patients with IPF and patients with PPF treated with nerandomilast demonstrated a smaller decline in forced vital ...
The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...
Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...
Explore more
For the second time this year, Leo Pharma has struck a partnership with a major drugmaker, this time paying Boehringer ...
LEO Pharma A/S agreed to acquire the global rights for skin disease drug Spevigo from Boehringer Ingelheim GmbH, as the ...
In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...
Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...
Most symptoms after stopping antidepressants are mild and don’t meet criteria for severe discontinuation syndrome, suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results